OptMed
New York
About OptMed
OptMed develops and commercializes biocompatible polymer and genitourinary therapeutic platforms. Its biocompatible polymers platform serves for biosurgical adhesive and sealant, and industrial adhesive applications. The company’s and genitourinary therapeutics platform serves for the treatment of lower urinary tract conditions, including overactive bladder and kidney stones. Its products include Devakor, a topical skin adhesive for surgical sutures. OptMed was incorporated in 2007 and is based in Woodmere, New York.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $9.2M
- Last round: Series Unknown (Aug 2015)
- Website: optmed.net
- Phone: (212) 867-4141
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/optmed-2779306 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.